Clinical Trial Update: A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of 552-02 for dry mouth in Sjögren's syndrome completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome
• Xerostomia

Drugs mentioned

• 552-02

Snippet

Sponsor: Parion Sciences | Conditions: Dry Mouth Associated With Sjogren's Syndrome, Xerostomia | Phase 2 | Status: COMPLETED